Trials / Recruiting
RecruitingNCT05231135
A Registry Study on HIV-related Lymphoma
Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Rotkreuzklinikum München gGmbH · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Detailed description
To study characteristics, treatment approaches and outcome of HIV-infected patients with malignant lymphoma in the combination antiretroviral therapy (cART) era. HIV-infected persons diagnosed with non-Hodgkin lymphoma or Hodgkin lymphoma will be included. The choice of treatment is not specified by the registry study. However, the type of antineoplastic treatment should follow national or international recommendations and guidelines. Data will be pseudonymized by the data manager of the treating institution. Central data management is located at Red Cross Hospital Munich, Germany.
Conditions
Timeline
- Start date
- 2021-08-25
- Primary completion
- 2024-08-31
- Completion
- 2029-08-31
- First posted
- 2022-02-09
- Last updated
- 2023-04-06
Locations
6 sites across 4 countries: Germany, Netherlands, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT05231135. Inclusion in this directory is not an endorsement.